Reversal of multidrug resistance by 5,5′-dimethoxylariciresinol-4-O- β-D-glucoside in doxorubicin-resistant human leukemia K562/DOX

Indian Journal of Pharmacology

Volumn 45, Issue 6, 2013, Pages 597-602

  Wang, Tian Xiao ^a   Shi, Xiao Yan ^a   Cong, Yue ^a   Wang, Shi Guang ^a,b   Wang, Ying Ying ^a   Zhang, Zhong Qin ^a  

^a HENAN UNIVERSITY   (China)

^b Zhengzhou Huaxin College   (China)

Author keywords

5 dimethoxylariciresinol 4 O D glucoside; doxorubicin; leukemia; multidrug resistance

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 5,5' DIMETHOXYLARICIRESINOL 4 O BETA DEXTRO GLUCOSIDE; DOXORUBICIN; GLUCOSAMINE DERIVATIVE; HOE 33342; MULTIDRUG RESISTANCE PROTEIN; PROPIDIUM IODIDE; RHODAMINE 123; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL STRAIN K 562; CHEMOSENSITIVITY; CHINESE MEDICINE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG SCREENING; DRUG SENSITIVITY; DRUG TRANSPORT; FLUORESCENCE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAHONIA; MULTIDRUG RESISTANCE; PROTEIN ANALYSIS; STAINING;

5,5'-DIMETHOXYLARICIRESINOL-4'-O-Β-D-GLUCOSIDE; DOXORUBICIN; LEUKEMIA; MULTIDRUG RESISTANCE;

ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; GLUCOSIDES; HUMANS; K562 CELLS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LIGNANS;

EID: 84890050385     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.121371     Document Type: Article

References (26)

1. Longley DB, Johnston PG. Molecular mechanisms of drug resistance. J Pathol 2005; 205: 275-92.
2. Tiwari AK, Sodani K, Chen ZS. Current advances in modulation of ABC transporter-mediated multidrug resistance in cancer. Int J Toxicol Pharmacol Res 2009; 1: 1-6.
3. Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361-98.
4. Ling V. Multidrug resistance: Molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 1997; 40 Suppl: S3-8.
5. Perez EA. Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer. Breast Cancer Res Treat 2009; 114: 195-201.
6. Svirnovski AI, Shman TV, Serhiyenka TF, Savitski VP, Smolnikova VV, Fedasenka UU. ABCB1 and ABCG2 proteins, their functional activity and gene expression in concert with drug sensitivity of leukemia cells. Hematology 2009; 14: 204-12.
7. Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, et al. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. Haematologica 2000; 85: 711-21.
8. Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy - From TCM theory to mechanistic insights. Planta Med 2010; 76: 1118-31.
9. Vuddanda PR, Chakraborty S, Singh S. Berberine: A potential phytochemical with multispectrum therapeutic activities. Expert Opin Investig Drugs 2010; 19: 1297-307.
10. Liu CH, Tang WR, Wang HM, Lee KC. Cancer patients' experience of combined treatment with conventional and traditional Chinese medicine: A biopsychosocial phenomenon. Cancer Nurs 2011; 34: 495-502.
11. Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, et al. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy. J Cancer Res Clin Oncol 2011; 137: 1117-22.
12. Hu W, Yu L, Wang MH. Antioxidant and antiproliferative properties of water extract from Mahonia bealei (Fort.) Carr. leaves. Food Chem Toxicol 2011; 49: 799-806.
13. Wong BS, Hsiao YC, Lin TW, Chen KS, Chen PN, Kuo WH, et al. The in vitro and in vivo apoptotic effects of Mahonia oiwakensis on human lung cancer cells. Chem Biol Interact 2009; 180: 165-74.
14. Cong Y, Wang Y, Wang TX. Chemical constituents from the stem of Mahonia bealei (Fort.) Carr. Chin Tradit Pat Med 2011; 33: 1008-110.
15. Berg D, Centrilla L, Halsey J, Silvester P, Jones B, Guynn K, et al. Overcoming multidrug resistance: Valspodar as a paradigm for nursing care. Oncol Nurs Forum 1999; 26: 711-20.
16. Covelli A. Modulation of multidrug resistance (MDR) in hematological malignancies. Ann Oncol 1999; 10 Suppl 6: 53-9.
17. Mahadevan D, List AF. Targeting the multidrug resistance-1 transporter in AML: Molecular regulation and therapeutic strategies. Blood 2004; 104: 1940-51.
18. Nobili S, Landini I, Giglioni B, Mini E. Pharmacological strategies for overcoming multidrug resistance. Curr Drug Targets 2006; 7: 861-79.
19. Sikic BI. Pharmacologic approaches to reversing multidrug resistance. Semin Hematol 1997; 34 Suppl 5: 40-7.
20. Lin C, Lin X, Yang J. An observation on combined use of chemotherapy and traditional Chinese medicine to relieve cancer pain. J Tradit Chin Med 1996; 16: 267-9.
21. Chan KK, Yao TJ, Jones B, Zhao JF, Ma FK, Leung CY, et al. The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: A double-blind placebo-controlled randomized trial with immunological monitoring. Ann Oncol 2011; 22: 2241-9.
22. Sadava D, Ahn J, Zhan M, Pang ML, Ding J, Kane SE. Effects of four Chinese herbal extracts on drug-sensitive and multidrug-resistant small-cell lung carcinoma cells. Cancer Chemother Pharmacol 2002; 49: 261-6.
23. Zhao TF, Wang XK, Rimando AM, Che CT. Folkloric medicinal plants: Tinospora sagittata var. cravaniana and Mahonia bealei. Planta Med 1991; 57: 505.
24. Chao J, Lu TC, Liao JW, Huang TH, Lee MS, Cheng HY, et al. Analgesic and anti-inflammatory activities of ethanol root extract of Mahonia oiwakensis in mice. J Ethnopharmacol 2009; 125: 297-303.
25. Li AR, Zhu Y, Li XN, Tian XJ. Antimicrobial activity of four species of Berberidaceae. Fitoterapia 2007; 78: 379-81.
26. Rohrer U, Kunz EM, Lenkeit K, Schaffner W, Meyer J. Antimicrobial activity of Mahonia aquifolium and two of its alkaloids against oral bacteria. Schweiz Monatsschr Zahnmed 2007; 117: 1126-31.